See also: Generic MetroCream, Generic MetroGel-Vaginal, Generic MetroLotion
MetroGel is a brand name of metronidazole topical, approved by the FDA in the following formulation(s):
METROGEL (metronidazole - gel; topical)
Manufacturer: GALDERMA LABS LP
Approval date: November 22, 1988
Strength(s): 0.75% [RLD][AB]
Manufacturer: GALDERMA LABS LP
Approval date: June 30, 2005
Strength(s): 1% [RLD][AB]
Has a generic version of MetroGel been approved?
A generic version of MetroGel has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to MetroGel and have been approved by the FDA:
metronidazole gel; topical
Manufacturer: FOUGERA PHARMS
Approval date: June 6, 2006
Strength(s): 0.75% [AB]
Manufacturer: G AND W LABS INC
Approval date: January 19, 2011
Strength(s): 0.75% [AB]
Manufacturer: TARO
Approval date: July 18, 2006
Strength(s): 0.75% [AB]
Manufacturer: TOLMAR
Approval date: July 13, 2006
Strength(s): 0.75% [AB]
Manufacturer: TOLMAR
Approval date: July 22, 2011
Strength(s): 1% [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of MetroGel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Aqueous compositions containing metronidazole
Patent 6,881,726
Issued: April 19, 2005
Inventor(s): Chang; Yunik & Dow; Gordon J.
Assignee(s): Dow Pharmaceutical Sciences
An aqueous solution of metronidazole in which the concentration of metronidazole is higher than 0.75%. The solution contains a combination of solubility-enhancing agents, one of which is a cyclodextrin such as beta-cyclodextrin and the second is a compound other than a cyclodextrin. Methods of manufacture and therapeutic use of the solution are disclosed.Patent expiration dates:
- February 21, 2022✓✓
- February 21, 2022
Aqueous compositions containing metronidazole
Patent 7,348,317
Issued: March 25, 2008
Inventor(s): Chang; Yunik & Dow; Gordon J.
Assignee(s): Dow Pharmaceutical Sciences
An aqueous solution of metronidazole in which the concentration of metronidazole is higher than 0.75%. The solution contains a combination of solubility-enhancing agents, one of which is a cyclodextrin such as beta-cyclodextrin and the second is niacin or niacinamide. Methods of manufacture and therapeutic use of the solution are disclosed.Patent expiration dates:
- February 21, 2022✓✓
- February 21, 2022
See also...
- MetroGel Cream Consumer Information (Wolters Kluwer)
- MetroGel Gel Consumer Information (Wolters Kluwer)
- MetroGel Consumer Information (Cerner Multum)
- Metrogel Topical Advanced Consumer Information (Micromedex)
- Metronidazole Cream Consumer Information (Wolters Kluwer)
- Metronidazole Emulsion Consumer Information (Wolters Kluwer)
- Metronidazole Gel Consumer Information (Wolters Kluwer)
- Metronidazole topical Consumer Information (Cerner Multum)
- Metronidazole vaginal Consumer Information (Cerner Multum)
- Flagyl Vaginal Advanced Consumer Information (Micromedex)
- Neo-Metric Advanced Consumer Information (Micromedex)
- Nidagel Advanced Consumer Information (Micromedex)
- Metronidazole Topical Advanced Consumer Information (Micromedex)
- Metronidazole Vaginal Advanced Consumer Information (Micromedex)
- Metronidazole topical AHFS DI Monographs (ASHP)
No comments:
Post a Comment